September has not been a month of reassurance. While Europe makes a cautious recovery, new policy rules, chemical restrictions and regulatory updates are pressing in. This comes exactly when shutdowns and turnarounds (ST/TA) will decide whether companies are not only compliant, but also profitable. What was once a technical maintenance or overhaul project is increasingly becoming an ROI stress test. And whoever fails to close the gaps in contractor management loses not only time, but also money, reputation and possibly market access.
New regulations hit operational deadlines
One of the most important developments is the revised PFAS restriction under an updated ECHA proposal, published on 20 August 2025. The PFAS restriction now covers more applications (sealing, technical textiles, machinery, medical packaging, catalysts, etc.). The proposal introduces options with transition periods (derogations), but also stricter requirements on emission reduction and lifecycle monitoring. At the same time, the public consultation on the revision of EU GMP Chapter 1 / Pharmaceutical Quality System runs until 3 December 2025. The revision requires organisations to embed Quality Risk Management and Knowledge Management even more firmly across the entire product lifecycle. The proposals emphasise proactive risk management, the use of data for batch trending (even when there are few batches) and the formalisation of governance structures for outsourced and contracted workstreams.
Why shutdowns & turnarounds are the ultimate benchmark
Shutdowns and turnarounds bring everything together: dozens or hundreds of contractors on site at once, critical parts shipped from far away, permits, documents, data quality, safety, compliance and logistics. If one link fails (contractor access, a PFAS materials supplier that does not deliver on time or compliantly, or an auditor who wants access to digital records), the whole chain slows down and the return is lost.
Take the impact of a one-day delay at a large chemical plant: lost production, higher energy costs, and possible fines or compensation claims. In pharma, a delayed GMP audit can lead to batch rejection. Every additional contractor problem has a direct cost. The new PFAS rules may require material comparisons, additional testing or substitutions, which increases inventory costs and CAPEX pressure. The GMP update to Chapter 1 demands more data tracing, which requires investment in digital systems and qualification processes.
Practical cases
- PFAS restriction
Companies that use sealing materials, gaskets or coatings are being forced to requalify suppliers or find alternatives. Those who had already planned for this with supplier audits, pre-qualification and lifecycle tracking are ahead. Those who must switch now see their supply chains falter, which leads to a backlog in ST/TA.
- GMP Chapter 1
For pharma sites that outsource, it is no longer enough for contractors to meet quality standards. You must demonstrate that the governance structure, risk assessment, knowledge management & batch data trending are in place. Sites that already have their documentation, access, training and data digitalisation in good order will pass audits faster, have less downtime and will not see their product release put at risk.
- Supply chain & logistics
With contractor turnover or deliveries of PFAS materials, expect longer lead times, disruption from customs checks and possible refusal at the border. Sites with alternative suppliers, dual sourcing or buffer stocks are less vulnerable.
Supply Chain Risk Management is not an extra cost item, but the lever for conversion
Contractors are no longer just the people who carry out the work. They sit on the critical path. How you qualify them, grant them access, manage documents and permits, and carry out audits makes the difference between profit and loss.
These are the concrete measures:
- Pre-qualification
Of contractors: check material use (PFAS-free or certified), safety certificates and data quality before ST/TA begins. - Permit-to-work & access systems
Linked to training, safety & compliance records. If a document is not up to date, there is no access. - DigitalisationA central contractor portal for training, qualification, material use, audits and permits, with dashboards that show in real time where the risks lie (suppliers, documents, compliance).
- Auditing & monitoringNot only of your contractors, but also of their suppliers (tier-n), especially for critical materials or PFAS use.
- Link governance and reporting
Connect site practice with what will soon be required under CSRD/ESRS, GMP Chapter 1 and the PFAS regulations. Make sure data is available to auditors immediately, not months later.
KPIs & role impact
Who sees what, who steers what
Below are KPIs and focus areas per role, to keep the focus on conversion sharp:
| Role | Key KPIs / focus areas |
COO / Site Director | ST/TA lead time vs planned time; number of contractor access errors on day 1; cost of material shipping / delays; % of contractors pre-qualified (incl. material/chemical use); audit finding score after ST/TA. |
Maintenance & Engineering | First-time-right material selection (PFAS-free or compliant); % of downtime caused by incorrectly qualified contractors; MTTR on units with external interventions; number of correctly documented interventions. |
HSE / Safety & Compliance | Number of incidents/response incidents caused by contractors / incomplete permits; number of permit-to-work deviations; training and access compliance ratio; audit findings with legal implications. |
Procurement / Supplier Management | Lead time of PFAS material suppliers; number of alternative suppliers; on-time delivery (OTIF) for critical materials; cost overruns due to substitution; contract clauses for compliance / material requirements. |
CIO / Digital/Operational Excellence | Percentage of contractor administration digitalised; availability of the contractor portal; time to audit evidence; real-time view of contractor status; data quality (completeness, traceability). |
Risk & Compliance | Risk score per contractor (material class, PFAS use, geographic risk); percentage of suppliers with a complete compliance profile; exposure to fines or failed audits; estimated financial impact of delays caused by compliance issues. |
Legal dimensions & timelines
- REACH & PFAS Restriction: PFAS regulation is now in the “Background Document” phase, with the Dossier Submitters (Denmark, Germany, the Netherlands, Norway, Sweden) adding eight additional sectors. The final opinions of ECHA’s RAC and SEAC are expected by the end of 2025, with a public consultation on SEAC’s draft opinion in the first half of 2026.
- GMP Chapter 1: The consultation runs until 3 December 2025. Changes such as knowledge management, risk analysis and product quality review will become mandatory. Sites must prepare now, because inspectors will require this.
Economic impact
Figures & forecasts
- PFAS restriction: more than 10,000 substances are in scope. With more sectors covered and new derogations, material suppliers and manufacturers face considerable CAPEX, either to find alternatives or to build in compliance measures.
- GMP Chapter 1: delays or non-compliance can lead to batch rejections that can cost millions of euros per case in pharma. Even a one-week delay in a turnaround (e.g. unavailable certified suppliers or missed training/records) can seriously erode margins at high-output sites.
- Total system costs (delays, fines, reputational damage) rise when the contractor flow is not flawless. Every gap in documentation, access or material requirements translates into extra working hours, more inspection hassle and possibly negative public exposure.
Growth & innovation depend on the strength of contractor management
Those who invest today in contractor management, compliance tools, digital traceability and governance are not only building certainty. They are creating a competitive advantage. At a time when PFAS restrictions, GMP updates and stricter reporting obligations are the norm, sites that manage their external workforce well can complete ST/TA faster, with fewer incidents, less audit damage, fewer fines and more trust from authorities and financiers.
Innovation is not enough. Only those who can perform quickly and credibly under pressure will win. Grow or be left behind.